-
Je něco špatně v tomto záznamu ?
The European Particle Therapy Network (EPTN) consensus on the follow-up of adult patients with brain and skull base tumours treated with photon or proton irradiation
L. De Roeck, HL. van der Weide, DBP. Eekers, MC. Kramer, C. Alapetite, M. Blomstrand, NG. Burnet, V. Calugaru, IEM. Coremans, D. Di Perri, S. Harrabi, A. Iannalfi, YLB. Klaver, JA. Langendijk, AM. Romero, F. Paulsen, E. Roelofs, D. de Ruysscher,...
Jazyk angličtina Země Irsko
Typ dokumentu časopisecké články, přehledy
- MeSH
- dospělí MeSH
- konsensus MeSH
- lidé MeSH
- mozek MeSH
- nádory baze lební * radioterapie MeSH
- následné studie MeSH
- protonová terapie * škodlivé účinky MeSH
- protony MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
PURPOSE: Treatment-related toxicity after irradiation of brain tumours has been underreported in the literature. Furthermore, there is considerable heterogeneity on how and when toxicity is evaluated. The aim of this European Particle Network (EPTN) collaborative project is to develop recommendations for uniform follow-up and toxicity scoring of adult brain tumour patients treated with radiotherapy. METHODS: A Delphi method-based consensus was reached among 24 international radiation-oncology experts in the field of neuro-oncology concerning the toxicity endpoints, evaluation methods and time points. RESULTS: In this paper, we present a basic framework for consistent toxicity scoring and follow-up, using multiple levels of recommendation. Level I includes all recommendations that are considered minimum of care, whereas level II and III are optional evaluations in the advanced clinical or research setting, respectively. Per outcome domain, the clinical endpoints and evaluation methods per level are listed. Where relevant, the organ at risk threshold doses for recommended referral to specific organ specialists are defined. CONCLUSION: These consensus-based recommendations for follow-up will enable the collection of uniform toxicity data of brain tumour patients treated with radiotherapy. With adoptation of this standard, collaboration will be facilitated and we can further propel the research field of radiation-induced toxicities relevant for these patients. An online tool to implement this guideline in clinical practice is provided at www.cancerdata.org.
Clinic for Particle Therapy University Hospital Essen West German Cancer Center Germany
Danish Centre for Particle Therapy Aarhus Denmark
Department of Oncology Sahlgrenska University Hospital Gothenburg Sweden
Department of Radiation Oncology Cliniques universitaires Saint Luc Brussels Belgium
Department of Radiation Oncology Eberhard Karls Universität Tübingen Germany
Department of Radiotherapy Erasmus MC Cancer Institute Rotterdam The Netherlands
German Cancer Consortium partnersite Essen Germany
German Cancer Research Center Heidelberg Germany
Haaglanden Medisch Centrum Department of Radiotherapy Leidschendam The Netherlands
Holland Proton Therapy Centre Delft The Netherlands
Institut Curie Radiation Oncology Department Paris and Proton Center Orsay France
Institute Curie Centre de Protonthérapie d'Orsay Orsay France
Institute of Radiooncology OncoRay Helmholtz Zentrum Dresden Rossendorf Germany
Leiden University Medical Centre Department of Radiotherapy The Netherlands
Leuven Kanker Instituut UZ Leuven Gasthuisberg Belgium
National Center for Oncological Hadrontherapy Pavia Italy
National Center for Tumour Diseases Partner Site Dresden Germany
Norwegian Radiation and Nuclear Safety Authority Oslo Norway
Particle Therapy Interuniversitary Center Leuven Belgium
Paul Scherrer Institut Center for Proton Therapy ETH Domain Villigen Switzerland
Proton Therapy Center Czech Prague Czech Republic
The Christie NHS Foundation Trust Manchester United Kingdom
University Hospitals Leuven Department of Radiation Oncology Belgium
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22019336
- 003
- CZ-PrNML
- 005
- 20220804135555.0
- 007
- ta
- 008
- 220720s2022 ie f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.radonc.2022.01.018 $2 doi
- 035 __
- $a (PubMed)35093408
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ie
- 100 1_
- $a De Roeck, Laurien $u KU Leuven, University of Leuven, Department of Oncology, Laboratory of Experimental Radiotherapy, Belgium; University Hospitals Leuven, Department of Radiation Oncology, Belgium. Electronic address: Laurien.deroeck@uzleuven.be
- 245 14
- $a The European Particle Therapy Network (EPTN) consensus on the follow-up of adult patients with brain and skull base tumours treated with photon or proton irradiation / $c L. De Roeck, HL. van der Weide, DBP. Eekers, MC. Kramer, C. Alapetite, M. Blomstrand, NG. Burnet, V. Calugaru, IEM. Coremans, D. Di Perri, S. Harrabi, A. Iannalfi, YLB. Klaver, JA. Langendijk, AM. Romero, F. Paulsen, E. Roelofs, D. de Ruysscher, B. Timmermann, P. Vitek, DC. Weber, GA. Whitfield, PW. Nyström, J. Zindler, EGC. Troost, M. Lambrecht, work package 1 of the taskforce “European Particle Therapy Network” of ESTRO
- 520 9_
- $a PURPOSE: Treatment-related toxicity after irradiation of brain tumours has been underreported in the literature. Furthermore, there is considerable heterogeneity on how and when toxicity is evaluated. The aim of this European Particle Network (EPTN) collaborative project is to develop recommendations for uniform follow-up and toxicity scoring of adult brain tumour patients treated with radiotherapy. METHODS: A Delphi method-based consensus was reached among 24 international radiation-oncology experts in the field of neuro-oncology concerning the toxicity endpoints, evaluation methods and time points. RESULTS: In this paper, we present a basic framework for consistent toxicity scoring and follow-up, using multiple levels of recommendation. Level I includes all recommendations that are considered minimum of care, whereas level II and III are optional evaluations in the advanced clinical or research setting, respectively. Per outcome domain, the clinical endpoints and evaluation methods per level are listed. Where relevant, the organ at risk threshold doses for recommended referral to specific organ specialists are defined. CONCLUSION: These consensus-based recommendations for follow-up will enable the collection of uniform toxicity data of brain tumour patients treated with radiotherapy. With adoptation of this standard, collaboration will be facilitated and we can further propel the research field of radiation-induced toxicities relevant for these patients. An online tool to implement this guideline in clinical practice is provided at www.cancerdata.org.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a mozek $7 D001921
- 650 _2
- $a konsensus $7 D032921
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a protonová terapie $x škodlivé účinky $7 D061766
- 650 _2
- $a protony $7 D011522
- 650 12
- $a nádory baze lební $x radioterapie $7 D019292
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a van der Weide, Hiska L $u Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands
- 700 1_
- $a Eekers, Daniëlle B P $u Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, The Netherlands
- 700 1_
- $a Kramer, Miranda C $u Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands
- 700 1_
- $a Alapetite, Claire $u Institut Curie, Radiation Oncology Department, Paris & Proton Center, Orsay, France
- 700 1_
- $a Blomstrand, Malin $u Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden
- 700 1_
- $a Burnet, Neil G $u The Christie NHS Foundation Trust, Manchester, United Kingdom
- 700 1_
- $a Calugaru, Valentin $u Institute Curie, Paris, France; Institute Curie, Centre de Protonthérapie d'Orsay, Orsay, France
- 700 1_
- $a Coremans, Ida E M $u Leiden University Medical Centre, Department of Radiotherapy, The Netherlands; Holland Proton Therapy Centre, Delft, The Netherlands
- 700 1_
- $a Di Perri, Dario $u Department of Radiation Oncology, Cliniques universitaires Saint-Luc, Brussels, Belgium; Particle Therapy Interuniversitary Center Leuven (PartICLe), Belgium
- 700 1_
- $a Harrabi, Semi $u Heidelberg Ion-Beam Therapy Centre (HIT), Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany
- 700 1_
- $a Iannalfi, Alberto $u National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy
- 700 1_
- $a Klaver, Yvonne L B $u Holland Proton Therapy Centre, Delft, The Netherlands
- 700 1_
- $a Langendijk, Johannes A $u Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands
- 700 1_
- $a Romero, Alejandra Méndez $u Holland Proton Therapy Centre, Delft, The Netherlands; Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
- 700 1_
- $a Paulsen, Frank $u Department of Radiation Oncology, Eberhard-Karls-Universität Tübingen, Germany
- 700 1_
- $a Roelofs, Erik $u Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, The Netherlands
- 700 1_
- $a de Ruysscher, Dirk $u Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, The Netherlands
- 700 1_
- $a Timmermann, Beate $u Clinic for Particle Therapy, University Hospital Essen, West German Cancer Center (WTZ), Germany; West German Proton Therapy Center Essen (WPE), Germany; German Cancer Consortium (DKTK), partnersite Essen, Germany
- 700 1_
- $a Vitek, Pavel $u Proton Therapy Center Czech, Prague, Czech Republic
- 700 1_
- $a Weber, Damien C $u Paul Scherrer Institut Center for Proton Therapy, ETH Domain, Villigen, Switzerland
- 700 1_
- $a Whitfield, Gillian A $u The University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, United Kingdom; The Children's Brain Tumour Research Network, University of Manchester, Royal Manchester Children's Hospital, United Kingdom
- 700 1_
- $a Nyström, Petra Witt $u Danish Centre for Particle Therapy, Aarhus, Denmark; Norwegian Radiation and Nuclear Safety Authority, Oslo, Norway
- 700 1_
- $a Zindler, Jaap $u Holland Proton Therapy Centre, Delft, The Netherlands; Haaglanden Medisch Centrum, Department of Radiotherapy, Leidschendam, The Netherlands
- 700 1_
- $a Troost, Esther G C $u German Cancer Consortium (DKTK), partnersite Essen, Germany; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden-Rossendorf, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumour Diseases (NCT), Partner Site Dresden, Germany
- 700 1_
- $a Lambrecht, Maarten $u KU Leuven, University of Leuven, Department of Oncology, Laboratory of Experimental Radiotherapy, Belgium; University Hospitals Leuven, Department of Radiation Oncology, Belgium; Particle Therapy Interuniversitary Center Leuven (PartICLe), Belgium; Leuven Kanker Instituut (LKI), UZ Leuven Gasthuisberg, Belgium
- 710 2_
- $a work package 1 of the taskforce “European Particle Therapy Network” of ESTRO
- 773 0_
- $w MED00004049 $t Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology $x 1879-0887 $g Roč. 168, č. - (2022), s. 241-249
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35093408 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804135548 $b ABA008
- 999 __
- $a ok $b bmc $g 1822790 $s 1170579
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 168 $c - $d 241-249 $e 20220129 $i 1879-0887 $m Radiotherapy and oncology $n Radiother Oncol $x MED00004049
- LZP __
- $a Pubmed-20220720
